Vanguard Group
AUGX

Vanguard Group’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Vanguard Group’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,589,255
Closed -$3.73M – 4379
2024
Q3 		$3.73M Buy
1,589,255
+177,000
+13% +$357K ﹤0.01% 3378
2024
Q2 		$1.24M Buy
1,412,255
+109,831
+8% +$226K ﹤0.01% 3718
2024
Q1 		$5.33M Buy
1,302,424
+179,534
+16% +$803K ﹤0.01% 3279
2023
Q4 		$6.57M Buy
1,122,890
+84,294
+8% +$444K ﹤0.01% 3177
2023
Q3 		$5.35M Buy
1,038,596
+47,252
+5% +$222K ﹤0.01% 3216
2023
Q2 		$4.77M Buy
991,344
+361,715
+57% +$1.25M ﹤0.01% 3325
2023
Q1 		$1.1M Hold
629,629
– – ﹤0.01% 3885
2022
Q4 		$982K Buy
629,629
+419
+0.1% +$534 ﹤0.01% 3922
2022
Q3 		$912K Hold
629,210
– – ﹤0.01% 4032
2022
Q2 		$1.13M Sell
629,210
-7,181
-1% -$16.6K ﹤0.01% 4043
2022
Q1 		$1.87M Buy
636,391
+22,994
+4% +$62.4K ﹤0.01% 3987
2021
Q4 		$1.93M Buy
+613,397
New +$2.22M ﹤0.01% 4049

Vanguard Group's AUGX Position: Q4 2024 in Review

Vanguard Group sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 1,589,255 shares — an estimated $3.73M sold.

Vanguard Group first reported a position in AUGX in Q4 2021 and held it in 12 quarters. The position peaked at $6.57M in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Vanguard Group reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Vanguard Group sold 1,589,255 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $3.73M.
  • Vanguard Group first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • Vanguard Group's Augmedix, Inc. Common Stock position peaked at $6.57M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.